Wednesday, July 8, 2026

pharma · Malaria · Pharmacokinetics · CNSP

CNS Pharmaceuticals

CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme

Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
Status
Public
HQ
Houston, TX 77027, US
Founded
2017
Employees
12
Programs
21
Drugs
18
Patents
0
Clinical program

SPR206

Phase 1 · small molecule · Healthy Volunteers

SPR206 for Healthy Volunteers is a Phase 1 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).

← All CNS Pharmaceuticals projects Phase 1 small molecule completed

Internal code SPR206-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
CNS Pharmaceuticals
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
completed
Trials
1

Clinical trials